| 摘要 |
A composition for the treatment of diabetes and a method of use thereof. The composition includes an immunoregulator, preferably Linomide, and a beta cell proliferative agent, preferably reg protein. The composition has been shown to be effective in both inhibiting the progression of diabetes, and reversing the course of the disease, in the NOD mouse model. |
